American Heart Journal
Volume 157, Issue 6 , Pages 1018-1025 , June 2009

Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: Findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

  • James D. Flaherty, MD

      Affiliations

    • Northwestern University, Chicago, IL
    • ,
  • Joseph S. Rossi, MD

      Affiliations

    • University of North Carolina, Chapel Hill, NC
    • ,
  • Gregg C. Fonarow, MD

      Affiliations

    • University of California Los Angeles Medical Center, Los Angeles, CA
    • Corresponding Author InformationReprint requests: Gregg C. Fonarow, MD, UCLA Division of Cardiology, 10833 LeConte Avenue, Los Angeles, CA 90095-1679.
    • ,
  • Eduardo Nunez, MD

      Affiliations

    • GlaxoSmithKline, Philadelphia, PA
    • ,
  • Wendy Gattis Stough, PharmD

      Affiliations

    • Duke University Medical Center, Durham, and Campbell University School of Pharmacy, Research Triangle Park, NC
    • ,
  • William T. Abraham, MD

      Affiliations

    • The Ohio State University, Columbus, OH
    • ,
  • Nancy M. Albert, PhD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Barry H. Greenberg, MD

      Affiliations

    • University of California San Diego, San Diego, CA
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Clyde W. Yancy, MD

      Affiliations

    • Baylor University Medical Center, Dallas, TX
    • ,
  • James B. Young, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Charles J. Davidson, MD

      Affiliations

    • Northwestern University, Chicago, IL
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Northwestern University, Chicago, IL

Received 18 January 2009 ,Accepted 6 March 2009.

References 

  1. Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112:3958–3968
  2. Thom T, Haase N, Rosamond W, et al. Heart Disease and Stroke Statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85–e151
  3. Gheorghiade M, Sopko G, De Luca L, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114:1202–1213
  4. Fox KF, Cowie MR, Wood DA, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J. 2001;22:228–236
  5. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–1084
  6. Bart BA, Shaw LK, McCants CB, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 1997;30:1002–1008
  7. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation. 2005;112:e154–e235
  8. Cleland JGF, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442–463
  9. Kurtz CE, Gerber Y, Weston SA, et al. Use of ejection fraction tests and coronary angiography in patients with heart failure. Mayo Clinic Proc. 2006;81:906–913
  10. Fonarow GC, Abraham WT, Albert NM, et al. Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148:43–51
  11. Ambler G, Brady AR, Royston P. Simplifying a prognostic model: a simulation study based on clinical data. Stat Med. 2002;21:3803–3822
  12. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28:964–974
  13. Harrell FE, Margolis PA, Gove S, et al. Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological agents of Pneumonia, Sepsis and Meningitis in Young Infants. Stat Med. 1998;17:909–944
  14. StataCorp . Stata Statistical Software: Release 9. Texas: College Station; 2005;
  15. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39:210–218
  16. O'Connor CM, Gattis WA, Shaw L, et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol. 2000;86:863–867
  17. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The STARS-BNP multicenter study. J Am Coll Cardiol. 2007;49:1733–1739
  18. Taylor AJ, Bindeman J, Feuerstein I, et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol. 2008;51:1337–1341
  19. Task Force on Acute Heart Failure . Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384–416
  20. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 Guideline Update for coronary artery bypass graft surgery. Circulation. 2004;110:1168–1176
  21. Smith SC, Feldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 Guideline Update for percutaneous coronary intervention. J Am Coll Cardiol. 2005;47:216–235
  22. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction. J Am Coll Cardiol. 2007;50:e1–e157
  23. Adams JKF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209–216
  24. Devlin G, Gore JM, Elliott J, et al. Management and 6-month outcomes in elderly and very elderly patients with high-risk non–ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Eur Heart J. 2008;29:1275–1282
  25. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non–ST-segment elevation acute coronary syndromes. Ann Intern Med. 2004;141:186–195
  26. Ozcan EE, Guneri S, Akdeniz B, et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J. 2007;154:539–544
  27. Schweiger MJ, Charles E, Chambers J, et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Cath CV Intervent. 2007;69:135–140
  28. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–1158
  29. Rott D, Behar S, Leor J, et al. Effect on survival of acute myocardial infarction in Killip classes II or III patients undergoing invasive coronary procedures. Am J Cardiol. 2001;88:618–623
  30. Rossi JS, Flaherty JD, Fonarow GC, et al. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes. Eur J Heart Fail. 2008;10:1215–1223
  31. Tavazzi L, Maggioni AP, Lucci D, et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006;27:1207–1215
  32. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28:980–988
  33. Roe MT, Chen AY, Riba AL, et al. Impact of congestive heart failure in patients with non–ST-segment elevation acute coronary syndromes. Am J Cardiol. 2006;97:1707–1712
  34. Steg PG, Dabbous OH, Feldman LJ, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 2004;109:494–499
  35. Shibata MC, Collinson J, Taneja AK, et al. Long term prognosis of heart failure after acute coronary syndromes without ST elevation. Postgrad Med J. 2006;82:55–59
  36. Spencer FA, Meyer TE, Gore JM, et al. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation. 2002;105:2605–2610
  37. Torabi A, Cleland JGF, Khan NK, et al. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J. 2008;29:859–870
  38. Fonarow GC, Gawlinski A, Moughrabi S, et al. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001;87:819–822
  39. Fonarow GC, Abraham WT, Albert NM, et al. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2007;153:82.e1–82.e11
  40. Applegate RJ, Sacrinty MT, Kutcher MA, et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. J Am Coll Cardiol Intv. 2008;1:317–326
  41. McCullough PA, Adam A, Becker CR, et al. for the CIN Consensus Working Panel Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006;985:5K–13K
  42. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61–70
  43. Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217–2226

 Clinical Trial.gov identifier: NCT00344513.

 Funding: OPTIMIZE-HF and this study were supported by GlaxoSmithKline, Philadelphia, PA.

 Dr William S. Weintraub served as guest editor for this manuscript.

PII: S0002-8703(09)00205-1

doi: 10.1016/j.ahj.2009.03.011

American Heart Journal
Volume 157, Issue 6 , Pages 1018-1025 , June 2009

Article Tools

* Image Usage & Resolution